ASCO GU 2020: New drug, sitravatinib in combination with nivolumab for second-line treatment of advanced kidney cancer
The results from one of the first clinical trials of [...]
The results from one of the first clinical trials of [...]
Results from the phase 1b COSMIC-021 study of cabozantinib in [...]